VSM Wealth Advisory LLC Purchases Shares of 228 iShares Biotechnology ETF (NASDAQ:IBB)

VSM Wealth Advisory LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 228 shares of the financial services provider’s stock, valued at approximately $30,000.

A number of other hedge funds also recently made changes to their positions in IBB. Cullen Frost Bankers Inc. lifted its holdings in shares of iShares Biotechnology ETF by 1.5% during the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock valued at $748,000 after acquiring an additional 82 shares in the last quarter. Transcend Capital Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 0.8% during the 4th quarter. Transcend Capital Advisors LLC now owns 10,958 shares of the financial services provider’s stock valued at $1,449,000 after acquiring an additional 92 shares in the last quarter. Chicago Partners Investment Group LLC lifted its holdings in shares of iShares Biotechnology ETF by 2.5% during the 4th quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after acquiring an additional 94 shares in the last quarter. WealthCare Investment Partners LLC lifted its holdings in shares of iShares Biotechnology ETF by 0.9% during the 4th quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock valued at $1,375,000 after acquiring an additional 96 shares in the last quarter. Finally, Capital Investment Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.4 %

NASDAQ:IBB opened at $132.74 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The firm has a market capitalization of $6.05 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77. The firm’s fifty day simple moving average is $136.21 and its 200 day simple moving average is $139.49.

iShares Biotechnology ETF Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, March 21st. Investors of record on Tuesday, March 18th will be paid a dividend of $0.1212 per share. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend is Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.